PF-8380
CAS No. 1144035-53-9
PF-8380 ( PF8380; PF-8380; PF 8380 )
Catalog No. M10512 CAS No. 1144035-53-9
Potent autotaxin inhibitor (IC50= 2.8 nM in isolated enzyme assay; 101 nM in human whole blood).
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 35 | In Stock |
|
10MG | 58 | In Stock |
|
25MG | 125 | In Stock |
|
50MG | 205 | In Stock |
|
100MG | 335 | In Stock |
|
200MG | 494 | In Stock |
|
500MG | 782 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePF-8380
-
NoteResearch use only, not for human use.
-
Brief DescriptionPotent autotaxin inhibitor (IC50= 2.8 nM in isolated enzyme assay; 101 nM in human whole blood).
-
DescriptionPotent autotaxin inhibitor (IC50= 2.8 nM in isolated enzyme assay; 101 nM in human whole blood). Modulates lysophosphatidic acid (LPA) levelsin vivoandin vitroby directly inhibiting autotaxin; reduces LPA levels both in plasma and at site of inflammation. Orally available.
-
SynonymsPF8380; PF-8380; PF 8380
-
PathwayAngiogenesis
-
TargetPDE
-
RecptorAutotaxin
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number1144035-53-9
-
Formula Weight478.33
-
Molecular FormulaC22H21Cl2N3O5
-
Purity>98%(HPLC)
-
SolubilityDMSO: 95 mg/mL (198.6 mM)
-
SMILESO=C(N1CCN(CCC(C2=CC=C3NC(OC3=C2)=O)=O)CC1)OCC4=CC(Cl)=CC(Cl)=C4
-
Chemical Name3,5-dichlorobenzyl 4-(3-oxo-3-(2-oxo-2,3-dihydrobenzo[d]oxazol-6-yl)propyl)piperazine-1-carboxylate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Gierse J, et al. J Pharmacol Exp Ther. 2010, 334(1):310-317.
molnova catalog
related products
-
CDP-840
CDP-840 (CDP840;L-765527) is a potent and selective PDE4 inhibitor with IC50 of 4-45 nM for PDE 4 extracted from tissues or recombinant PDE 4 isoforms expressed in yeast.
-
Enpp-1-IN-14
ENPP1-IN-2 is a potent inhibitor of Ectonucleotide Pyrophosphatase/Phosphodiesterase-1 (ENPP1) with an IC50 value of 32.38 nM for recombinant human ENPP-1. ENPP1-IN-2 has anti-tumor activity.
-
CHF6001
A novel, highly potent and selective phosphodiesterase 4 (PDE4) inhibitor with IC50 of 0.026 nM.